DalsnaFinance › IPOs › Passage Bio › IPO
Passage BIO, Inc. completed its initial public offering on NASDAQ on February 28, 2020, pricing at $18.00 a share.
| Ticker | PASG |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | February 28, 2020 |
| Offering price | $18.00 |
| Shares offered | 12,000,000 |
| Total raised | $216M |
Passage BIO, Inc. sold 12,000,000 shares at $18.00 each on NASDAQ. Multiplied out, that is $216 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $216 million total recorded for the deal.
Passage BIO, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Passage BIO, Inc.. This page is general information, not investment advice.